Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Tài liệu Báo cáo khoa học: Site-directed mutagenesis of a loop at the active site of E1 (a2b2) of
Nội dung xem thử
Mô tả chi tiết
Site-directed mutagenesis of a loop at the active site of E1 (a2b2)
of the pyruvate dehydrogenase complex
A possible common sequence motif
Markus Fries*, Hitesh J. Chauhan†
, Gonzalo J. Domingo‡
, Hyo-Il Jung§ and Richard N. Perham
Cambridge Centre for Molecular Recognition, Department of Biochemistry, University of Cambridge, UK
Limited proteolysis of the pyruvate decarboxylase (E1, a2b2)
component of the pyruvate dehydrogenase (PDH) multienzyme complex ofBacillus stearothermophilus has indicated
the importance for catalysis of a site (Tyr281-Arg282) in the
E1a subunit (Chauhan, H.J., Domingo, G.J., Jung, H.-I. &
Perham, R.N. (2000) Eur. J. Biochem. 267, 7158–7169). This
site appears to be conserved in the a-subunit of heterotetrameric E1s and multiple sequence alignments suggest
that there are additional conserved amino-acid residues in
this region, part of a common pattern with the consensus
sequence -YR-H-D-YR-DE-. This region lies about 50
amino acids on the C-terminal side of a 30-residue motif
previously recognized as involved in binding thiamin
diphosphate (ThDP) in all ThDP-dependent enzymes. The
role of individual residues in this set of conserved amino
acids in the E1a chain was investigated by means of sitedirected mutagenesis. We propose that particular residues
are involved in: (a) binding the 2-oxo acid substrate,
(b) decarboxylation of the 2-oxo acid and reductive acetylation of the tethered lipoyl domain in the PDH complex,
(c) an open–close mechanism of the active site, and
(d) phosphorylation by the E1-specific kinase (in eukaryotic
PDH and branched chain 2-oxo acid dehydrogenase complexes).
Keywords: pyruvate dehydrogenase; multienzyme complex;
thiamin diphosphate; limited proteolysis; enzyme mechanism.
The family of 2-oxo acid dehydrogenase (2-OADH) multienzyme complexes contains three members: the pyruvate
dehydrogenase (PDH), the 2-oxoglutarate dehydrogenase
(OGDH) and the branched-chain 2-oxo acid dehydrogenase
(BCDH) complexes. These are responsible for the oxidative
decarboxylation of pyruvate, 2-oxoglutarate and branchedchain 2-oxo acids, respectively, in each case generating the
corresponding acyl-CoA and NADH. The complexes all
occupy important positions in the metabolism of the cell
and generally comprise three component enzymes: a 2-oxo
acid decarboxylase (E1, EC 1.2.4), a dihydrolipoyl acyltransferase (E2, EC 2.3.1), and dihydrolipoyl dehydrogenase (E3, EC 1.8.1.4). E1 catalyses the first and irreversible
step of the overall reaction, the thiamin-diphosphate
(ThDP)-dependent oxidative decarboxylation of the 2-oxo
acid, followed by the reductive acylation of a lipoyl
prosthetic group covalently bound to a lysine residue in
the lipoyl domain of the E2 chain. The reaction catalysed by
E1 is rate-limiting for the overall activity of the complex
[1,2], probably at the reductive acylation step [2,3]. The E2
component catalyses the transfer of the acyl group from the
lipoyl-lysine group to CoA, and the cycle is completed by
reoxidation of the resulting dihydrolipoyl group catalysed
by E3, a flavoprotein, generating NADH and H+ from
NAD+. For recent reviews, see de Kok et al. and Perham
[4,5].
In eukaryotic PDH and BCDH complexes, modulation
of catalytic activity is achieved by phosphorylationdephosphorylation of E1; an E1-specific kinase inactivates
E1 by phosphorylating certain serine residues in the E1a
component and activity is restored by the action of a specific
phosphatase [6–8]. Depending on the organism and the type
of 2-OADH complex, the E1 component exists either as a
heterotetramer (a2b2) or a homodimer (a2). In the PDH
complexes of Gram-negative bacteria and in all OGDH
complexes, E1 is a homodimer; in PDH complexes of
Correspondence to R. N. Perham, Department of Biochemistry,
University of Cambridge, Sanger Building, Old Addenbrooke’s Site,
80 Tennis Court Road, Cambridge CB2 1GA, UK.
Fax: + 44 1223 333667, Tel.: + 44 1223 333663,
E-mail: [email protected]
Abbreviations: BCDH, branched-chain 2-oxo acid dehydrogenase;
DCPIP, 2,6-dichlorophenolindophenol; E1, 2-oxo acid decarboxylase;
E1a, alpha subunit of E1; E1b, beta subunit of E1; E1p, pyruvate
decarboxylase of PDH complex; E2p, dihydrolipoyl acetyltransferase;
E3, dihydrolipoyl dehydrogenase; IPTG, isopropyl thio-b-D-galactoside; OGDH, 2-oxoglutarate dehydrogenase; PSBD, peripheral
subunit-binding domain; SPR, surface plasmon resonance;
ThDP, thiamin diphosphate.
Enzymes: pyruvate decarboxylase (EC 1.2.4.1); dihydrolipoyl acetyltransferase (EC 2.3.1.12); dihydrolipoyl dehydrogenase (EC 1.8.1.4).
*Present address: Cambridge Institute for Medical Research,
Wellcome Trust/MRC Building, Box139 Addenbrooke’s Hospital,
Hills Road, Cambridge CB2 2XY, UK.
Present address: Adprotech Ltd, Chesterford Research Park, Little
Chesterford, Saffron Walden, Essex CB10 1XL, UK.
Present address: Seattle Biomedical Research Institute, 4 Nickerson
Street, Seattle, WA 98109, USA.
§Present address: Wolfson Institute for Biomedical Research, The
Cruciform Building, Gower Street, London WC1E 6BT, UK.
(Received 19 September 2002, revised 5 December 2002,
accepted 20 December 2002)
Eur. J. Biochem. 270, 861–870 (2003) FEBS 2003 doi:10.1046/j.1432-1033.2003.03444.x